Tris Pharma, Inc. announced today the completion of its company's expansion to a state of the art research and manufacturing facility in South Brunswick, New Jersey.

Considered a milestone advancement for the company, representatives feel that the Food and Drug Administration's (FDA) approval of the expansion marks its ongoing growth and success as a partner and provider of innovative drug delivery technologies which will allow them to leverage their line of drug delivery technologies and services.

Tris Pharma is a specialty drug delivery technology company which specializes in controlled release dosage forms for liquid, solid and orally- disintegrating tablets; abuse-deterrent technology; and bioavailability enhancement of poorly absorbed drugs  and has more than 30 products in development, submission or on market.

Source: Tris Pharma, Inc.